1. Home
  2. IMMX vs PAYS Comparison

IMMX vs PAYS Comparison

Compare IMMX & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

N/A

Current Price

$7.92

Market Cap

784.8M

Sector

Health Care

ML Signal

N/A

Logo Paysign Inc.

PAYS

Paysign Inc.

N/A

Current Price

$9.51

Market Cap

780.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMX
PAYS
Founded
2014
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
784.8M
780.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
IMMX
PAYS
Price
$7.92
$9.51
Analyst Decision
Strong Buy
Buy
Analyst Count
7
5
Target Price
★ $24.05
$14.81
AVG Volume (30 Days)
★ 1.2M
1.2M
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 85.71
EPS
N/A
★ 0.30
Revenue
N/A
★ $24,120,434.00
Revenue This Year
N/A
$40.90
Revenue Next Year
N/A
$12.70
P/E Ratio
★ N/A
$31.48
Revenue Growth
★ N/A
N/A
52 Week Low
$3.78
$3.08
52 Week High
$15.10
$16.15

Technical Indicators

Market Signals
Indicator
IMMX
PAYS
Relative Strength Index (RSI) 42.67 26.49
Support Level $7.82 $8.26
Resistance Level $9.04 $14.06
Average True Range (ATR) 0.62 1.17
MACD 0.16 -0.68
Stochastic Oscillator 41.81 3.13

Price Performance

Historical Comparison
IMMX
PAYS

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.

Share on Social Networks: